Your browser doesn't support javascript.
loading
Bedaquiline-based all-oral regimen for macrolide-resistant Mycobacterium abscessus pulmonary disease.
Riccardi, N; Occhineri, S; Matucci, T; Marchetti, G; Rindi, L; Tiseo, G; Cirillo, D M; Falcone, M.
Affiliation
  • Riccardi N; Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, StopTB Italia, Milan.
  • Occhineri S; Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, StopTB Italia, Milan.
  • Matucci T; Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, StopTB Italia, Milan.
  • Marchetti G; Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, StopTB Italia, Milan.
  • Rindi L; Microbiology Department of Clinical and Experimental Medicine, University of Pisa, Pisa.
  • Tiseo G; Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa.
  • Cirillo DM; Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation, and Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele, Milan, Italy.
  • Falcone M; Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa.
Int J Tuberc Lung Dis ; 27(9): 712-713, 2023 09 01.
Article in En | MEDLINE | ID: mdl-37608476
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Macrolides / Mycobacterium abscessus Limits: Humans Language: En Journal: Int J Tuberc Lung Dis Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Macrolides / Mycobacterium abscessus Limits: Humans Language: En Journal: Int J Tuberc Lung Dis Year: 2023 Type: Article